Female and Male Contraception

Part I Overview on contraception: Birth control methods: from ancient times to the future.- Best practices for contraceptive counseling.- Contraception and sexuality.- Contraception and mood.- Part II Female contraceptives: Non-hormonal contraceptives.- The SARCs: combined hormonal contraceptives and progestin-only pills.- The advantages of LARC methods.- Medical eligibility criteria for contraceptive use.- Venous and arteriosus risks associated with old and new oral contraceptive formulations.- Non-contraceptive benefits of hormonal methods.- Oncologic risks and prevention.- Emergency contraception.- Part III Management of female contraception throughout women's lifetime: Contraception and issues specific to adolescents.- Post-partum and peri-abortion contraception.- Contraception in the premenopausal women.- Contraceptive choice in women with PCOS.- Part IV Management of female contraception in women with medical conditions: Contraception in women with cardiovascular diseases.- Contraception in women with metabolic diseases.- Contraception in women with neurological diseases.- Contraception in women with oncological conditions.- Contraception in women with rheumatologic diseases and post transplantation.- Drug interactions with contraceptives.- Bone health and contraception .- Part V Male contraception: current options and ongoing research : The male role in family planning today.- Acceptability of male hormonal contraception.- Male contraception: non-hormonal methods.- Male contraception: hormonal methods.

Maria Cristina Meriggiola is an Associate Professor at the Clinic of Obstetrics and Gynecology, S Orsola Hospital and the Department of Medical and Surgical Sciences, University of Bologna. She is a temporary member of the scientific and technical advisory group of the Special Programmme of Human Reproduction and Reproductive Health Research (STAG) WHO, Geneva with focus on male hormonal contraception. She is a clinical researcher with a particular interest in male hormonal contraception, hormonal treatment in the transgender population and menopause. Kristina Gemzell-Danielsson is a Professor and Chair of the Division of Neonatology, Obstetrics and Gynecology and Head of the Department of Women's and Children's Health, Karolinska Institutet and Senior Consultant in Obstetrics and Gynaecology at the Karolinska University Hospital. She is Head of the research group at the WHO collaborating Centre for research and research training in Human Reproduction. She is Honorary Clinical Professor at Hong Kong University, and Honorary Fellow of the FSRH, RCOG, UK. Kristina Gemzell Danielsson was a member of the International Committee for Contraceptive Research (ICCR), Population Council. She is past President of the European Society for Contraception and Reproductive Health, and FIAPAC, member of the scientific and technical advisory group of the Special Programmme of Human Reproduction and Reproductive Health Research (STAG) WHO, Geneva, the International Medical Advisory Panel (IMAP) IPPF and member of the Nobel Assembly, Karolinska Institutet. Her research is translational (experimental and clinical trials "from bench to bed to the hands of women") with a focus on endometrial function, embryo implantation, induced abortion, emergency contraception and development of new contraceptive technology.